Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence

Detalles Bibliográficos
Autores principales: Sharun, Khan, Tiwari, Ruchi, Dhama, Jaideep, Dhama, Kuldeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IJS Publishing Group Ltd. Published by Elsevier Ltd. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472975/
https://www.ncbi.nlm.nih.gov/pubmed/32896649
http://dx.doi.org/10.1016/j.ijsu.2020.08.038
_version_ 1783579092959887360
author Sharun, Khan
Tiwari, Ruchi
Dhama, Jaideep
Dhama, Kuldeep
author_facet Sharun, Khan
Tiwari, Ruchi
Dhama, Jaideep
Dhama, Kuldeep
author_sort Sharun, Khan
collection PubMed
description
format Online
Article
Text
id pubmed-7472975
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher IJS Publishing Group Ltd. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74729752020-09-08 Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence Sharun, Khan Tiwari, Ruchi Dhama, Jaideep Dhama, Kuldeep Int J Surg Correspondence IJS Publishing Group Ltd. Published by Elsevier Ltd. 2020-10 2020-09-04 /pmc/articles/PMC7472975/ /pubmed/32896649 http://dx.doi.org/10.1016/j.ijsu.2020.08.038 Text en © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Sharun, Khan
Tiwari, Ruchi
Dhama, Jaideep
Dhama, Kuldeep
Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
title Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
title_full Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
title_fullStr Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
title_full_unstemmed Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
title_short Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
title_sort dexamethasone to combat cytokine storm in covid-19: clinical trials and preliminary evidence
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472975/
https://www.ncbi.nlm.nih.gov/pubmed/32896649
http://dx.doi.org/10.1016/j.ijsu.2020.08.038
work_keys_str_mv AT sharunkhan dexamethasonetocombatcytokinestormincovid19clinicaltrialsandpreliminaryevidence
AT tiwariruchi dexamethasonetocombatcytokinestormincovid19clinicaltrialsandpreliminaryevidence
AT dhamajaideep dexamethasonetocombatcytokinestormincovid19clinicaltrialsandpreliminaryevidence
AT dhamakuldeep dexamethasonetocombatcytokinestormincovid19clinicaltrialsandpreliminaryevidence

Ejemplares similares